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Background: Recent multicenter studies demonstrating a robust prognostic utility of Coronary computed tomography angiography (CCTA) for the 
prediction of mortality and other major adverse cardiac events(MACE). But till now, only few studies are aimed at the prediction of mortality and 
other MACE in asymptomatic diabetic patients.
methods: We have enrolled 2866 asymptomatic, adult diabetic patients from 2005 to 2011. CCTA scans were performed in 955 patients, and 
1910 patients were enrolled as control group with no CCTA scans. Control group was matched with CCTA scan group in age, gender with 2:1 ratio. All 
patients had a follow-up for death, MI, stroke with a median duration of 31 months.
results: CCTA scan group had a longer DM duration (12.45±9.5 vs. 10.19±8.98, p<0.001), higher HbA1c(8±1.94 vs. 7.59±1.8, p<0.001), 
BUN(18.42±9.14 vs. 17.13±7.32, p<0.001), Cr(1.03±0.56 vs 0.92±0.22, p<0.001) level, and lower Hb(13.52±1.67 vs. 13.27±1.82, p=0.01), 
AST(27.25±35.82 vs. 23.71±9.89, p<0.001), premeal C-peptide(2.12±2.31 vs. 1.8±1.26, p<0.001) level. Univariate Hazard Ratio in CCTA scan 
group for all death had no statistical significance (HR 0.729, 95% CI 0.494-1.075, p=0.111). After adjusting for multivariables, CCTA scan group still 
showed no statistical significance (HR 0.896, 95% CI 0.579-1.386, p=0.621).
conclusions: Performing CCTA scans in asymptomatic diabetic patients as a routine screening study has no benefit in all-cause mortality. 
